Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Cancer. 2010 Mar 15;116(6):1476–1484. doi: 10.1002/cncr.24861

Table III.

(a): Pathologic response after surgical assessment of CCR patients (N=55)
Type of response Number of patients (%)
NCI MGH Total
Pathologic CR (PCR) 16 10 26 (47)
Microscopic residual (M)* 18 2 20 (36)
Gross Residual (PPR) 6 3 9 (16)
PCR + M (eligible for surgery) 34/40 (85) 12/15 (80) 46/55 (84)
(b): Clinical response: intent-to-treat (N=62)
Type of response Number of patients (%)
NCI MGH Total
CCR 40 15 55 (89)
PR 2 0 2 (3)
SD 3 0 3 (5)
NE 1* 1 1
Overall Clinical RR 42 (91) 15 (94) 57 (92)
*

includes a patient who did not undergo second look but was found to have microscropic residual on a procedure performed to relieve a small bowel obstruction.

*

pt withdrew after 2 cycles with unconfirmed PR and tinnitus.